MediPharm Labs (TSE:LABS) Sets New 52-Week Low – Here’s Why

Shares of MediPharm Labs Corp. (TSE:LABS) hit a new 52-week low during mid-day trading on Monday. The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 123,354 shares trading hands. The stock had previously closed at C$0.07.

MediPharm Labs Trading Up 16.7%

The company has a quick ratio of 3.10, a current ratio of 2.69 and a debt-to-equity ratio of 1.19. The stock has a market capitalization of C$29.90 million, a P/E ratio of -7.00 and a beta of -0.44. The company has a fifty day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.07.

About MediPharm Labs

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.